Recent studies reveal that the global herbal medicine market is experiencing a compound annual growth rate (CAGR) of over 8%, projected to surpass USD 415 billion by 2030. Despite its rich biodiversity — with over 2,300 species of medicinal plants — Iran currently holds less than 0.5% of the global herbal export market.
Global Herbal Medicine Market Surges Toward $415 Billion — A Golden Opportunity for Iran and the Region
Across the MENA region, countries such as the UAE, Saudi Arabia, Egypt, and Turkey are investing heavily in traditional and complementary medicine, positioning themselves as emerging hubs in the natural pharmaceutical industry. Iran, with its scientific infrastructure, deep-rooted knowledge in traditional Persian medicine, and abundant natural resources, is well-positioned to reclaim a leading role in the herbal sector.
Experts emphasize that Iran’s herbal industry can grow significantly through value chain development, support for herbal health startups, export-oriented branding, and technological integration — including artificial intelligence and nanotechnology in phytopharmaceutical production.
With strategic investment and international partnerships, Iran and its regional peers could become influential players in shaping the future of natural and plant-based healthcare.
